Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML
- Status
- WITHDRAWN
- Phase
- PHASE2
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions
- Status
- COMPLETED
- Phase
- PHASE2
Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE3
Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2
High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Amifostine in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2